DBV Technologies | DBVT - Ebitda

Prezzo Delle Azioni
22.19
Cambio Giornaliero
0.11 0.50%
Mensile
-0.14%
Annuale
431.43%
Q1 Previsione
20.46




Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
DBV Technologies USD -33.48M 5.55M 2025-09
Esperion Therapeutics USD -27.51M 9.5M 2023-09
Galectin Therapeutics USD -7.42M 819K 2021-12
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Incyte USD 414.5M 92.42M 2025-12
Insmed USD -314.19M 31.48M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
PTC Therapeutics USD 20.63M 53.74M 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12